Dyslipidemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MDGL | B | Madrigal Pharmaceuticals, Inc. | -0.30 | |
IONS | B | Ionis Pharmaceuticals, Inc. | -1.15 | |
ARGX | B | argenx SE | 0.97 | |
VKTX | D | Viking Therapeutics, Inc. | 4.36 | |
ABT | D | Abbott Laboratories | -0.68 |
Related Industries: Biotechnology Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHI | C | iShares U.S. Medical Devices ETF | 16.36 | |
EWK | C | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
PJP | A | PowerShares Dynamic Pharmaceuticals | 5.9 | |
SURI | B | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 5.58 | |
BBH | B | Market Vectors Biotech ETF | 5.18 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
- Dyslipidemia
Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles